June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Intravitreal use of povidone-iodine to treat bacterial endophthalmitis
Author Affiliations & Notes
  • Ahmet Hondur
    Ophthalmology, Columbia University College of Physicians and Surgeons, New York, New York, United States
    Ophthalmology, Gazi University, Ankara, Turkey
  • Kayhan Caglar
    Microbiology, Gazi University, Ankara, Turkey
  • Gizem Duman
    Microbiology, Gazi University, Ankara, Turkey
  • Qun Zeng
    Ophthalmology, Columbia University College of Physicians and Surgeons, New York, New York, United States
  • Cristina Molero
    Ophthalmology, Columbia University College of Physicians and Surgeons, New York, New York, United States
  • Tongalp H Tezel
    Ophthalmology, Columbia University College of Physicians and Surgeons, New York, New York, United States
  • Footnotes
    Commercial Relationships   Ahmet Hondur, None; Kayhan Caglar, None; Gizem Duman, None; Qun Zeng, None; Cristina Molero, None; Tongalp Tezel, None
  • Footnotes
    Support  Research to Prevent Blindness, Inc, New York, NY. Slomo and Cindy Silvian Foundation, New York, NY
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4256. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Ahmet Hondur, Kayhan Caglar, Gizem Duman, Qun Zeng, Cristina Molero, Tongalp H Tezel; Intravitreal use of povidone-iodine to treat bacterial endophthalmitis. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4256.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine the safe and efficient concentration of povidone-iodine that can be used to sterilize the globe in cases of endophthalmitis.

Methods : Full-thickness human retina explants were harvested from freshly enucleated (<24 hours) eyes, and 6-mm patches of the retina were incubated with different concentrations (10% - 0.125%) of povidone-iodine at 37 °C within a humidified incubator for up to 48 hours. Retinal patches kept in CO2-independent medium served as controls. At the end of the incubation period retinal cell viability was determined using an ethidinium/calcein-based assay. Quantitative suspension test method was also employed on a Staphylococcus aureus strain to test the antibacterial effects of the studied povidone-iodine concentrations. Results were used to determine the optimum concentration of the povidone-iodine that can achieve the maximum antibacterial effect without retinal toxicity.

Results : Concentrations of povidone-iodine below 0.5% did not impair the retinal cell viability for up to 48 hours (97.5% vs 96.5%, p = 0.57). Bactericidal effect was observed with all studied concentrations of povidone-iodine; however, this bactericidal effect was more remarkable at concentrations at or above 0.5%.

Conclusions : Concentrations of povidone-iodine at or below 0.5% can be used to sterilize the globe without causing any retinal cytotoxicity for up to 48 hours. While 0.5% povidone-iodine can be used for the treatment of endophthalmitis and eliminate the concern of bacterial resistance, lower concentrations can be useful for prophylactic purposes after intraocular surgeries or traumatic globe injuries.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×